Xiao Zheng
Xiao Zheng
1Department of Tumor Biological Treatment, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
2Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, 213003 People’s Republic of China
3Institute of Cell Therapy, Soochow University, Changzhou, 213003 People’s Republic of China
1,2,3,
Lujun Chen
Lujun Chen
1Department of Tumor Biological Treatment, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
2Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, 213003 People’s Republic of China
3Institute of Cell Therapy, Soochow University, Changzhou, 213003 People’s Republic of China
1,2,3,
You Zhou
You Zhou
1Department of Tumor Biological Treatment, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
2Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, 213003 People’s Republic of China
3Institute of Cell Therapy, Soochow University, Changzhou, 213003 People’s Republic of China
1,2,3,
Qi Wang
Qi Wang
1Department of Tumor Biological Treatment, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
2Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, 213003 People’s Republic of China
3Institute of Cell Therapy, Soochow University, Changzhou, 213003 People’s Republic of China
1,2,3,
Zhuojun Zheng
Zhuojun Zheng
2Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, 213003 People’s Republic of China
4Department of Hematology, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
2,4,
Bin Xu
Bin Xu
1Department of Tumor Biological Treatment, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
2Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, 213003 People’s Republic of China
3Institute of Cell Therapy, Soochow University, Changzhou, 213003 People’s Republic of China
1,2,3,
Chen Wu
Chen Wu
2Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, 213003 People’s Republic of China
3Institute of Cell Therapy, Soochow University, Changzhou, 213003 People’s Republic of China
5Department of Oncology, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
2,3,5,
Qi Zhou
Qi Zhou
5Department of Oncology, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
5,
Wenwei Hu
Wenwei Hu
1Department of Tumor Biological Treatment, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
2Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, 213003 People’s Republic of China
5Department of Oncology, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
1,2,5,
Changping Wu
Changping Wu
1Department of Tumor Biological Treatment, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
2Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, 213003 People’s Republic of China
5Department of Oncology, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
1,2,5,
Jingting Jiang
Jingting Jiang
1Department of Tumor Biological Treatment, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
2Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, 213003 People’s Republic of China
3Institute of Cell Therapy, Soochow University, Changzhou, 213003 People’s Republic of China
1,2,3,✉
1Department of Tumor Biological Treatment, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
2Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, 213003 People’s Republic of China
3Institute of Cell Therapy, Soochow University, Changzhou, 213003 People’s Republic of China
4Department of Hematology, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
5Department of Oncology, the Third Affiliated Hospital of Soochow University, Changzhou, 213003 People’s Republic of China
© The Author(s) 2021
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.